Spatial Genomics & Transcriptomics Market by Technique, Product, Application and End-user - Global Forecast to 2025

News provided by

Dec 16, 2020, 16:15 ET

DUBLIN, Dec. 16, 2020 /PRNewswire/ -- The "Spatial Genomics & Transcriptomics Market by Technique (Spatial Transcriptomics, Spatial Genomics), Product (Instruments, Consumables, Software), Application (Drug Discovery), End User (Academic Institute, Research Institutes, CROs) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The global spatial genomics and transcriptomics market is projected to reach USD 404 million by 2025 from USD 178 million in 2020, at a CAGR of 17.8% during the forecast period.

Market growth is largely driven by the increasing adoption of spatial genomics and transcriptomics analysis among small companies and startups, expanding applications in biomarker identification and drug discovery & development, and increasing investment in biopharmaceutical R&D. On the other hand, lack of awareness about these techniques in the emerging countries and the high cost of instruments are some factors limiting the market growth.

By application, the translational research accounted for the largest share of the spatial genomics & transcriptomics market

Based on application, the spatial genomics and transcriptomics market is categorized into translational research and drug discovery & development. The translation research segment dominated the market in 2019, owing to increased investments by researchers in biomarker identification using spatial genomics and transcriptomics techniques.

Asia Pacific: The fastest-growing region in the spatial genomics & transcriptomics market.

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, mainly due to the growing biopharmaceutical industry, increasing life science research, rising investments by pharmaceutical and biotechnology companies, and the growing number of CROs and CMOs in several APAC countries contribute to its growth.

North America: the largest share of the spatial genomics & transcriptomics market

North America accounted for the largest share of the spatial genomics & transcriptomics market. Factors such as the to the presence of an established biopharmaceutical industry and the presence of major players operating in the spatial genomics & transcriptomics market in the region are the major factors driving the market growth.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Spatial Genomics and Transcriptomics Market Overview
4.2 North America: Spatial Genomics and Transcriptomics Market Share, by Product & Country (2019)
4.3 Spatial Genomics and Transcriptomics Market Share, by End-user (2019)
4.4 Spatial Genomics and Transcriptomics Market, by Application, 2020 Vs. 2025 (USD Million)
4.5 Spatial Genomics and Transcriptomics Market: Geographic Growth Opportunities

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Adoption of Spatial Genomics & Transcriptomics in Drug Discovery & Development
5.2.1.2 Introduction of Novel Products
5.2.1.3 Increasing R&D Investments and Public-Private Funding
5.2.2 Restraints
5.2.2.1 High Capital Investments
5.2.3 Opportunities
5.2.3.1 Increasing Use of Spatial Omics for Biomarker Identification
5.2.4 Challenges
5.2.4.1 Dearth of Skilled Professionals
5.3 Pricing Analysis
5.4 Impact of COVID-19 on the Spatial Genomics & Transcriptomics Market

6 Spatial Genomics and Transcriptomics Market, by Technique
6.1 Introduction
6.2 Spatial Transcriptomics
6.2.1 Immunohistochemistry (Ihc)
6.2.1.1 Emergence of Multiplex Immunohistochemistry/ Immunofluorescence (MIHC/IF) is Likely to Propel Growth in this Segment
6.2.2 in Situ Hybridization
6.2.2.1 High Adoption of Merfish Technique to Drive the Growth of this Segment
6.2.3 Sequencing Technologies
6.2.3.1 Microdissection-Based Sequencing
6.2.3.1.1 Increasing Use of Microdissection-Based Sequencing Techniques is Likely to Contribute Towards Market Growth
6.2.3.2 in Situ Sequencing Technologies
6.2.3.2.1 Increased Adoption of in Situ Sequencing Technologies is Likely to Drive the Growth of the Sequencing Technology Segment
6.2.3.3 Other Sequencing Technologies
6.2.4 Microscopy-Based Rna Imaging
6.2.4.1 Increasing Utilization of Microscopy-Based Rna Imaging Techniques for Spatial Analysis to Drive Segmental Growth
6.2.5 Other Spatial Transcriptomics Techniques
6.3 Spatial Genomics Analysis
6.3.1 Fluorescence in Situ Hybridization (Fish)
6.3.1.1 Emerging Potential of Spatial Genomics Analysis as a Cancer Diagnostic Tool is Likely to Propel Segmental Growth
6.3.2 Sequencing Techniques
6.3.2.1 Growing Adoption of Massively-Parallel Sequencing to Boost Growth in this Market Segment
6.3.3 Other Spatial Genomics Analysis Techniques

7 Spatial Genomics and Transcriptomics Market, by Product
7.1 Introduction
7.2 Consumables
7.2.1 Growing Use of Consumables for Various Spatial Genomics and Transcriptomics Applications to Drive Market Growth
7.3 Instruments
7.3.1 Introduction of Novel Instruments to Drive Growth in this Market Segment
7.4 Software
7.4.1 Increasing Use of Spatial Omics for Disease Diagnosis is Propelling the Demand for Software

8 Spatial Genomics and Transcriptomics Market, by Application
8.1 Introduction
8.2 Translational Research
8.2.1 Increased Funding for Research Activities to Propel the Growth of this Application Segment
8.3 Drug Discovery & Development
8.3.1 Increasing Use of Spatial Genomics and Transcriptomics in Drug Discovery & Development Applications to Drive Market Growth

9 Spatial Genomics and Transcriptomics Market, by End-user
9.1 Introduction
9.2 Academic & Research Institutes
9.2.1 Increase in Research Intensity to Drive the Use of Spatial Genomics and Transcriptomics in Academic & Research Institutes
9.3 Contract Research Organizations
9.3.1 Increasing Dependence on Contract Research Organizations for R&D by Market Players to Drive Market Growth
9.4 Pharmaceutical & Biotechnology Companies
9.4.1 Growing Importance of Biomarkers to Drive the Use of Spatial Genomics & Transcriptomics Systems & Services in Pharma & Biotech Companies

10 Spatial Genomics and Transcriptomics Market, by Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 the US Dominates the North American Spatial Genomics and Transcriptomics Market During the Forecast Period
10.2.2 Canada
10.2.2.1 Government Initiatives Are Supporting the Growth of the Market in Canada
10.3 Europe
10.3.1 Germany
10.3.1.1 Increasing Adoption of Spatial Genomics and Transcriptomics by Biopharma & Biotech Companies in Germany to Drive Market Growth
10.3.2 UK
10.3.2.1 Rising Government Support for Biotech Companies to Propel the Demand for Advanced Technologies, Including Spatial Genomics & Transcriptomics
10.3.3 France
10.3.3.1 Increasing Investments in Life Science R&D Infrastructure Development to Support Market Growth
10.3.4 Rest of Europe (RoE)
10.4 Asia-Pacific (APAC)
10.4.1 China
10.4.1.1 Increasing R&D Spending by Government and Biopharma Companies to Support Market Growth
10.4.2 Japan
10.4.2.1 Increased Research Funding in Japan Has Created Growth Opportunities for Spatial Genomics & Transcriptomics Research
10.4.3 Rest of Asia-Pacific (Roapac)
10.5 Latin America (Latam)
10.5.1 Brazil
10.5.1.1 Increased Adoption of Spatial Analysis for Translational Research in Brazil Likely to Propel the Market
10.5.2 Mexico
10.5.2.1 Increasing Investments in the Biotechnology Industry to Drive Market Growth in Mexico
10.5.3 Rest of Latin America (Rolatam)
10.6 Middle East & Africa (Mea)
10.6.1 South Africa
10.6.1.1 Growing Investments in Research & Development Support Market Development
10.6.2 Rest of Middle East & Africa (Romea)

11 Competitive Landscape
11.1 Overview
11.2 Right-To-Win Approaches Adopted by Key Market Players
11.3 Market Share Analysis
11.4 Key Market Developments
11.4.1 Key Product Launches
11.4.2 Key Mergers & Acquisitions
11.4.3 Key Partnerships, Agreements, and Collaborations
11.4.4 Expansions

12 Company Evaluation Matrix and Company Profiles
12.1 Spatial Genomics and Transcriptomics Market: Company Evaluation Matrix, 2019
12.1.1 Stars
12.1.2 Emerging Leaders
12.1.3 Pervasive Players
12.1.4 Participants
12.2 Company Profiles
12.2.1 Nanostring Technologies, Inc.
12.2.1.1 Business Overview
12.2.1.2 Products Offered
12.2.1.3 Recent Developments
12.2.1.4 SWOT Analysis
12.2.1.5 Analyst's View
12.2.2 10X Genomics, Inc.
12.2.2.1 Business Overview
12.2.2.2 Products Offered
12.2.2.3 Recent Developments
12.2.2.4 SWOT Analysis
12.2.2.5 Analyst's View
12.2.3 Illumina Inc.
12.2.3.1 Business Overview
12.2.3.2 Products Offered
12.2.3.3 Recent Developments
12.2.3.4 SWOT Analysis
12.2.3.5 Analyst's View
12.2.4 Bio-Rad Laboratories, Inc.
12.2.4.1 Business Overview
12.2.4.2 Products Offered
12.2.4.3 Recent Developments
12.2.5 Bio-Techne
12.2.5.1 Business Overview
12.2.5.2 Products Offered
12.2.5.3 Recent Developments
12.2.6 Fluidigm Corporation
12.2.6.1 Business Overview
12.2.6.2 Products Offered
12.2.6.3 Recent Developments
12.2.7 Genomic Vision
12.2.7.1 Business Overview
12.2.7.2 Products Offered
12.2.8 Seven Bridges Genomics
12.2.8.1 Business Overview
12.2.8.2 Products Offered
12.2.8.3 Recent Developments
12.2.9 Readcoor, Inc.
12.2.9.1 Business Overview
12.2.9.2 Products Offered
12.2.9.3 Recent Developments
12.2.10 S2 Genomics, Inc.
12.2.10.1 Business Overview
12.2.10.2 Products Offered
12.2.10.3 Recent Developments
12.2.11 Dovetail Genomics
12.2.11.1 Business Overview
12.2.11.2 Products Offered
12.2.11.3 Recent Developments
12.2.12 Akoya Biosciences, Inc.
12.2.12.1 Business Overview
12.2.12.2 Products Offered
12.2.13 Vizgen Corp.
12.2.13.1 Business Overview
12.2.13.2 Products Offered
12.2.14 Biospyder, Inc.
12.2.14.1 Business Overview
12.2.14.2 Products Offered
12.2.15 Optical Biosystems, Inc.
12.2.15.1 Business Overview
12.2.15.2 Products Offered
12.2.16 Miltenyi Biotec
12.2.16.1 Business Overview
12.2.16.2 Products Offered
12.2.16.3 Recent Developments
12.2.17 Rarecyte, Inc.
12.2.17.1 Business Overview
12.2.17.2 Products Offered
12.2.17.3 Recent Developments
12.2.18 Ultivue, Inc.
12.2.18.1 Business Overview
12.2.18.2 Products Offered
12.2.18.3 Recent Developments
12.2.19 Cytiva
12.2.19.1 Business Overview
12.2.19.2 Products Offered

13 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/8ciw9v

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets